185 related articles for article (PubMed ID: 33383049)
1. Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats.
Zhan C; Bai N; Zheng M; Wang Y; Wang Y; Zhang L; Li J; Li G; Zhao H; Liu G; Lou Q; Yang W; Li T; Li L; Li W
Life Sci; 2021 Feb; 267():118984. PubMed ID: 33383049
[TBL] [Abstract][Full Text] [Related]
2. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery.
Shiota N; Okunishi H; Takai S; Mikoshiba I; Sakonjo H; Shibata N; Miyazaki M
Circulation; 1999 Mar; 99(8):1084-90. PubMed ID: 10051304
[TBL] [Abstract][Full Text] [Related]
3. Scoparone alleviates Ang II-induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress.
Lyu L; Chen J; Wang W; Yan T; Lin J; Gao H; Li H; Lv R; Xu F; Fang L; Chen Y
J Cell Mol Med; 2021 Mar; 25(6):3136-3148. PubMed ID: 33560596
[TBL] [Abstract][Full Text] [Related]
4. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of tranilast on hypertrophic collagen production in the spontaneously hypertensive rat heart.
Umemura K; Kikuchi S; Suzuki Y; Nakashima M
Jpn J Pharmacol; 1998 Oct; 78(2):161-7. PubMed ID: 9829619
[TBL] [Abstract][Full Text] [Related]
6. Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis.
Guo T; Chen WQ; Zhang C; Zhao YX; Zhang Y
Atherosclerosis; 2009 Nov; 207(1):59-67. PubMed ID: 19446292
[TBL] [Abstract][Full Text] [Related]
7. Polyphenol rich ethanolic extract from Boerhavia diffusa L. mitigates angiotensin II induced cardiac hypertrophy and fibrosis in rats.
A P; Varghese MV; S A; P SR; Mathew AK; Nair A; Nair RH; K G R
Biomed Pharmacother; 2017 Mar; 87():427-436. PubMed ID: 28068633
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms.
Rahimi O; Kirby J; Varagic J; Westwood B; Tallant EA; Gallagher PE
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H883-H894. PubMed ID: 32083974
[TBL] [Abstract][Full Text] [Related]
9. Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis.
Chen Y; Huang M; Yan Y; He D
Bioengineered; 2021 Dec; 12(1):8447-8456. PubMed ID: 34663163
[TBL] [Abstract][Full Text] [Related]
10. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of tranilast on prostaglandin D synthetase.
Ikai K; Ujihara M; Fujii K; Urade Y
Biochem Pharmacol; 1989 Aug; 38(16):2673-6. PubMed ID: 2475113
[TBL] [Abstract][Full Text] [Related]
12. Tranilast stabilizes the accumulation and degranulation of resident mast cells while reducing cardiomyocyte apoptosis in a swine model of coronary microembolisation.
Zhang QY; Li JB; Wang ZH; Li XB; Yin LH; Wei M
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):641-6. PubMed ID: 20132236
[TBL] [Abstract][Full Text] [Related]
13. Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat.
Pinto YM; Pinto-Sietsma SJ; Philipp T; Engler S; Kossamehl P; Hocher B; Marquardt H; Sethmann S; Lauster R; Merker HJ; Paul M
Hypertension; 2000 Nov; 36(5):747-54. PubMed ID: 11082138
[TBL] [Abstract][Full Text] [Related]
14. Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats.
Zare MFR; Rakhshan K; Aboutaleb N; Nikbakht F; Naderi N; Bakhshesh M; Azizi Y
Life Sci; 2019 Sep; 232():116623. PubMed ID: 31279781
[TBL] [Abstract][Full Text] [Related]
15. Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II.
Jin D; Takai S; Shiota N; Miyazaki M
Eur J Pharmacol; 1998 Nov; 361(2-3):199-205. PubMed ID: 9865509
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Thiamine Hydrochloride on Cardiac Function, Redox Status and Morphometric Alterations in Doxorubicin-Treated Rats.
Radonjic T; Rankovic M; Ravic M; Zivkovic V; Srejovic I; Jeremic J; Jeremic N; Sretenovic J; Matic S; Jakovljevic V; Nikolic Turnic T
Cardiovasc Toxicol; 2020 Apr; 20(2):111-120. PubMed ID: 31270735
[TBL] [Abstract][Full Text] [Related]
17. Chymase-dependent production of angiotensin II: an old enzyme in old hearts.
Froogh G; Pinto JT; Le Y; Kandhi S; Aleligne Y; Huang A; Sun D
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H223-H231. PubMed ID: 27815252
[TBL] [Abstract][Full Text] [Related]
18. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.
Lin H; Zhang J; Ni T; Lin N; Meng L; Gao F; Luo H; Liu X; Chi J; Guo H
J Cell Mol Med; 2019 Sep; 23(9):6034-6047. PubMed ID: 31225944
[TBL] [Abstract][Full Text] [Related]
19. Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties.
Baba A; Tachi M; Ejima Y; Endo Y; Toyama H; Matsubara M; Saito K; Yamauchi M; Miura C; Kazama I
Cell Physiol Biochem; 2016; 38(1):15-27. PubMed ID: 26741745
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
Li P; Chen PM; Wang SW; Chen LY
Hypertens Res; 2002 Sep; 25(5):757-62. PubMed ID: 12452330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
